Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statement of Comprehensive Income

v3.21.2
Consolidated Statement of Comprehensive Income - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2021
Sep. 30, 2020
Consolidated Statement of Comprehensive Income      
Revenue   $ 47,910  
Other operating income $ 1,250,056   $ 1,963,670
Administrative expenses (887,995) (14,559,321) (2,772,642)
Reverse acquisition expense   (155,459,939)  
Nasdaq listing expenses   (2,589,611)  
Operating (loss)/profit 362,061 (172,560,961) (808,972)
Fair value movement on loss in warrant valuation   (98,090,070)  
Finance costs (88,466) (1,078,070) (392,783)
Finance income 510,252   64,902
(Loss)/profit before tax 783,847 (271,729,101) (1,136,853)
Income tax credit 253,718   568,534
(Loss)/profit for the financial year attributable to equity holders 1,037,565 (271,729,101) (568,319)
Items that may be reclassified to profit or loss      
Currency translation differences (38,897) 384,664 52,614
Total comprehensive loss for the year attributable to equity holders $ 998,668 $ (271,344,437) $ (515,705)
Basic and diluted earnings per ordinary share from continuing operations attributable to equity holders $ 0.0175 $ (3.9769) $ (0.0096)